Analysis of baseline parameters in the HALT polycystic kidney disease trials

Kidney International

Volumn 81, Issue 6, 2012, Pages 577-585

  Torres, Vicente E ^a   Chapman, Arlene B ^b   Perrone, Ronald D ^c   Bae, K Ty ^d   Abebe, Kaleab Z ^d   Bost, James E ^d   Miskulin, Dana C ^c   Steinman, Theodore I ^e   Braun, William E ^f   Winklhofer, Franz T ^g   Hogan, Marie C ^a   Oskoui, Frederic R ^b   Kelleher, Cass ^h   Masoumi, Amirali ^h   Glockner, James ^a   Halin, Neil J ^c   Martin, Diego R ^b   Remer, Erick ^f   Patel, Nayana ^h   Pedrosa, Ivan ^e   Wetzel, Louis H ^g   Thompson, Paul A ⁱ   Miller, J Philip ^j   Meyers, Catherine M ^k   Schrier, Robert W ^h   more..

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ SANFORD RESEARCH   (United States)

^j WASHINGTON UNIVERSITY   (United States)

^k NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

ADPKD; chronic renal disease; kidney volume; polycystic kidney disease; renal function

Indexed keywords

ALBUMIN; ALDOSTERONE; CLONIDINE; LABETALOL; LISINOPRIL; POTASSIUM; TELMISARTAN;

ADULT; ALDOSTERONE URINE LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; LIVER CYST; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; POSTNATAL GROWTH; POTASSIUM BLOOD LEVEL; PRENATAL GROWTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL SYSTEM PARAMETERS; SEX DIFFERENCE;

EID: 84857789154     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.411     Document Type: Article

References (68)

1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301. (Pubitemid 46552051)
2. Schrier RW. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2009; 20: 1888-1893.
3. Chapman AB, Torres VE, Perrone RD et al. The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol 2010; 5: 102-109.
4. Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 2006; 1: 148-157.
5. Chapman A, Johnson A, Gabow P et al. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994; 5: 1349-1354. (Pubitemid 24977120)
6. Chapman A, Guay-Woodford L, Grantham JJ et al. Renal structure in early autosomal dominant polycystic kidney disease (ADPKD); the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney Int 2003; 64: 1035-1045. (Pubitemid 37013840)
7. Grantham JJ, Torres VE, Chapman AB et al. Volume progression in polycystic kidney disease. N Engl J Med 2006; 354: 2122-2130. (Pubitemid 43736612)
8. Chapman AB, Bost JE, Torres VE et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011. (Submitted).
9. Lettre G. Genetic regulation of adult stature. Curr Opin Pediatr 2009; 21: 515-522.
10. Sovio U, Bennett AJ, Millwood IY et al. Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genet 2009; 5: e1000409.
11. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571-633. (Pubitemid 40404637)
12. Harder T, Plagemann A, Harder A. Birth weight and risk of neuroblastoma: a meta-analysis. Int J Epidemiol 2010; 39: 746-756.
13. Ou SX, Han D, Severson RK et al. Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 2002; 13: 15-25. (Pubitemid 34163947)
14. Rangel M, Cypriano M, de Martino Lee ML et al. Leukemia, non-Hodgkin's lymphoma, and Wilms tumor in childhood: the role of birth weight. Eur J Pediatr 2010; 169: 875-881.
15. Smith A, Lightfoot T, Simpson J et al. Birth weight, sex and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 2009; 33: 363-367.
16. Bergstrom A, Lindblad P, Wolk A. Birth weight and risk of renal cell cancer. Kidney Int 2001; 59: 1110-1113. (Pubitemid 32206874)
17. Cnattingius S, Lundberg F, Sandin S et al. Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prevent 2009; 18: 2422-2426.
18. Wernli K, Newcomb P, Wang Y et al. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res 2010; 20: 305-309.
19. Xu X, Dailey AB, Peoples-Sheps M et al. Birth weight as a risk factor for breast cancer: a meta-analysis of 18 epidemiological studies. J Women's Health 2009; 18: 1169-1178.
20. Luyckx VA, Brenner BM. The clinical importance of nephron mass. J Am Soc Nephrol 2010; 21: 898-910.
21. Bertram JF, Douglas-Denton RN, Diouf B et al. Human nephron number: implications for health and disease. Pediatr Nephrol 2011; 26: 1529-1533.
22. Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A et al. Kidneyspecific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet 2007; 16: 3188-3196. (Pubitemid 350131335)
23. Piontek K, Menezes LF, Garcia-Gonzalez MA et al. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 2007; 13: 1490-1495. (Pubitemid 350224245)
24. Takakura A, Contrino L, Beck AW et al. Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol 2008; 19: 2351-2363.
25. Cerhan JR, Sellers TA, Janney CA et al. Prenatal and perinatal correlates of adult mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005; 14: 1502-1508. (Pubitemid 40807353)
26. Botton J, Heude B, Maccario J et al. Postnatal weight and height growth velocities at different ages between birth and 5 y and body composition in adolescent boys and girls. Am J Clin Nutr 2008; 87: 1760-1768. (Pubitemid 351872640)
27. Hemachandra AH, Howards PP, Furth SL et al. Birth weight, postnatal growth, and risk for high blood pressure at 7 years of age: results from the Collaborative Perinatal Project. Pediatrics 2007; 119: e1264-e1270. (Pubitemid 46871243)
28. Leunissen RW, Kerkhof GF, Stijnen T et al. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 2009; 301: 2234-2242.
29. Singhal A, Cole TJ, Fewtrell M et al. Promotion of faster weight gain in infants born small for gestational age: is there an adverse effect on later blood pressure? Circulation 2007; 115: 213-220. (Pubitemid 46105720)
30. Singhal A, Cole TJ, Fewtrell M et al. Breastmilk feeding and lipoprotein profile in adolescents born preterm: follow-up of a prospective randomised study. Lancet 2004; 363: 1571-1578. (Pubitemid 38625658)
31. Ben-Shlomo Y, McCarthy A, Hughes R et al. Immediate postnatal growth is associated with blood pressure in young adulthood: the Barry Caerphilly Growth Study. Hypertension 2008; 52: 638-644.
32. Huxley R, Neil A, Collins R. Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet 2002; 360: 659-665. (Pubitemid 35232333)
33. Singhal A, Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis? Lancet 2004; 363: 1642-1645. (Pubitemid 38625670)
34. Sutter NB, Bustamante CD, Chase K et al. A single IGF1 allele is a major determinant of small size in dogs. Science 2007; 316: 112-115. (Pubitemid 46559530)
35. Gohlke BC, Schreiner F, Fimmers R et al. Insulin-like growth factor-I in cord blood is predictive of catch-up growth in monozygotic twins with discordant growth. J Clin Endocrinol Metab 2010; 95: 5375-5381.
36. Hansen-Pupp I, Lofqvist C, Polberger S et al. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res 2011; 69: 448-453.
37. Randhawa R, Cohen P. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 2005; 86: 84-90. (Pubitemid 41412163)
38. Nakamura T, Ebihara I, Nagaoka I et al. Growth factor gene expression in kidney of murine polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1378-1386.
39. Parker E, Newby LJ, Sharpe CC et al. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system. Kidney Int 2007; 72: 157-165. (Pubitemid 47067385)
40. Grigore D, Ojeda NB, Alexander BT. Sex differences in the fetal programming of hypertension. Gend Med 2008; 5(Suppl A): S121-S132. (Pubitemid 351455237)
41. Owens JA, Thavaneswaran P, De Blasio MJ et al. Sex-specific effects of placental restriction on components of the metabolic syndrome in young adult sheep. Am J Physiol Endocrinol Metab 2007; 292: E1879-E1889. (Pubitemid 47084727)
42. Ozaki T, Nishina H, Hanson MA et al. Dietary restriction in pregnant rats causes gender-related hypertension and vascular dysfunction in offspring. J Physiol 2001; 530: 141-152. (Pubitemid 32998894)
43. Woods LL, Ingelfinger JR, Rasch R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Phys Regul Integr Comp Physiol 2005; 289: R1131-R1136. (Pubitemid 41397063)
44. Flanagan DE, Moore VM, Godsland IF et al. Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis. Am J Physiol Endocrinol Metab 2000; 278: E700-E706. (Pubitemid 30215182)
45. Parker L, Lamont DW, Unwin N et al. A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years. Diabet Med 2003; 20: 406-415. (Pubitemid 36605627)
46. Li S, Chen SC, Shlipak M et al. Low birth weight is associated with chronic kidney disease only in men. Kidney Int 2008; 73: 637-642. (Pubitemid 351264117)
47. Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008; 19: 151-157.
48. Hallan S, Euser AM, Irgens LM et al. Effect of intrauterine growth restriction on kidney function at young adult age: the Nord Trondelag Health (HUNT 2) Study. Am J Kidney Dis 2008; 51: 10-20. (Pubitemid 350296514)
49. Moritz KM, Cuffe JSM, Wilson LB et al. Review: sex specific programming: a critical role for the renal renin-angiotensin system. Placenta 2010; 31: S40-S46.
50. King BF, Torres VE, Brummer ME et al. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomaldominant polycystic kidney disease. Kidney Int 2003; 64: 2214-2221. (Pubitemid 37449557)
51. Koomans HA, Roos JC, Boer P et al. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 1982; 4: 190-197.
52. Navaneethan SD, Nigwekar SU, Sehgal AR et al. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4: 542-551.
53. Schrier RW, Regal EM. Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease. Kidney Int 1972; 1: 156-168.
54. Orskov B, Romming Sorensen V, Feldt-Rasmussen B et al. Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol 2010; 5: 2034-2039.
55. Gabow P, Johnson A, Kaehny W et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-1319.
56. Bae KT, Zhu F, Chapman AB et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Clin J Am Soc Nephrol 2006; 1: 64-69.
57. Kathiresan S, Larson MG, Benjamin EJ et al. Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens 2005; 18: 657-665. (Pubitemid 40692433)
58. Chidambaram M, Duncan JA, Lai VS et al. Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephro 2002; 13: 446-452. (Pubitemid 34106287)
59. Szmuilowicz ED, Adler GK, Williams JS et al. Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrinol Metab 2006; 91: 3981-3987. (Pubitemid 44536873)
60. Braley LM, Menachery AI, Yao T et al. Effect of progesterone on aldosterone secretion in rats. Endocrinology 1996; 137: 4773-4778. (Pubitemid 26403318)
61. Stachenfeld NS, Taylor HS. Progesterone increases plasma volume independent of estradiol. J Appl Physiol 2005; 98: 1991-1997. (Pubitemid 40726888)
62. Quinkler M, Meyer B, Bumke-Vogt C et al. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol 2002; 146: 789-799.
63. Saner-Amigh K, Mayhew BA, Mantero F et al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab 2006; 91: 1136-1142. (Pubitemid 43357792)
64. Clark BG, Wheatley R, Rawlings JL et al. Female preponderance in diureticassociated hypokalemia: a retrospective study in seven long-term care facilities. J Am Geriatr Soc 1982; 30: 316-321. (Pubitemid 12071026)
65. Toner JM, Ramsay LE. Thiazide-induced hypokalaemia; prevalence higher in women. Br J Clin Pharmacol 1984; 18: 449-452. (Pubitemid 14033833)
66. Zheng W, Shi M, You SE et al. Estrogens contribute to a sex difference in plasma potassium concentration: a mechanism for regulation of adrenal angiotensin receptors. Gend Med 2006; 3: 43-53.
67. Lasker N, Hopp L, Grossman S et al. Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase. J Clin Invest 1985; 75: 1813-1820.
68. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.